Skip to main content
BRNS logo

BRNS · Barinthus Biotherapeutics plc. · Holdings

Track BRNS — free
$0.74 -0.02 (-2.49%) At close · Sep 8
Market Cap
$30.23M
Shares
40.85M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 15
Total Value: $6,074,203
Total Shares: 9,203,348

Institutional Ownership Trend

21 quarters

Holder Concentration

Across 15 13F filers · Δ vs Mar 31, 2026
Top Holder
56.5%
Sep 2023 → Jun 2026 · range 52.4% – 65.8%
+0.6 pts
Top 5
94.4%
Sep 2023 → Jun 2026 · range 93.2% – 97.0%
+1.2 pts
Top 10
99.3%
Sep 2023 → Jun 2026 · range 99.2% – 99.8%
−0.0 pts
HHI
3,668
Sep 2023 → Jun 2026 · range 3,268 – 4,727
Highly concentrated+72

Quarterly Activity

vs Mar 31, 2026
New
3
Increased
2
Decreased
2
Sold Out
2
Unchanged
8
Holder count: +1
Institutional value: +14.8%
Shares held: -1.0%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 15 of 15
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1828185 CUSIP 91864C107 13F (30d) 6 filings 6 filers Visit website Investor relations